SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-13-005475
Filing Date
2013-09-30
Accepted
2013-09-30 17:30:33
Documents
2
Period of Report
2013-09-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092513_soligenixinc.htm 8-K 57844
2 SOLIGENIX, INC. 2005 EQUITY INCENTIVE PLAN, AS AMENDED ON SEPTEMBER 25, 2013. f8k092513ex10i_soligenixinc.htm EX-10.1 122625
  Complete submission text file 0001213900-13-005475.txt   182045
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 131124243
SIC: 2834 Pharmaceutical Preparations